AI help for pulmonary fibrosis clinic
Part of Lungs & breathing clinical trials.
This study tests if artificial intelligence can improve care for people with pulmonary fibrosis. It involves filling out a questionnaire to help doctors learn more about your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at the lung disease clinic at Fondazione Policlinico A. Gemelli.
- You are able and willing to sign a consent form.
- You are not the person who sent any of the emails used for the questionnaire.
- You can fill out the questionnaire without help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to help doctors decide if you should be tested for pulmonary hypertension (high blood pressure in the lungs), which can be a complication of interstitial lung disease. If the tool suggests you might have it, you may get an echocardiogram (an ultrasound of the heart) and a right heart catheterization (a test to measure pressure in the heart) to find out for sure.
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
Hear when a new Interstitial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.